文献速递关节外科

模块化双动髋假体患者的血液金属水平、白细胞谱与细胞因子谱:前瞻性队列早期结果

Blood metal levels, leucocyte profiles, and cytokine profiles in patients with a modular dual-mobility hip prosthesis: early results from a prospective cohort study.
PubMed 文献 · Bone Joint J · 2019-01-01

本研究前瞻性纳入39例接受模块化双动全髋关节置换术患者并随访至两年,临床性能良好;7例在3个月、2例在2年时血钴轻度升高,血清IL-4、IL-5和IFNγ术后较术前显著降低(p<0.05),无失败症状。结论提示模块化双动全髋关节置换术似乎是安全的。

要点

  • 39例模块化双动全髋关节置换患者随访至两年,临床性能良好,无失败症状。
  • 血钴轻度升高见于7例3个月和2例2年时;铬在3个月3例、1年2例、2年3例可检测到。
  • 术后血清IL-4、IL-5和IFNγ较术前显著降低(p<0.05),循环白细胞谱保持稳定。

核心结论

  • 模块化双动全髋关节置换术似乎是安全的,允许使用大股骨头和厚聚乙烯承重面,在翻修或需要额外稳定性的高风险情况下尤其有用。

研究设计与样本

  • 前瞻性队列研究,共招募39例接受模块化双动全髋关节置换术的患者,临床随访至两年。

主要发现

  • 临床性能良好,无患者出现提示失败的症状。
  • 血钴水平(参考值1.0 µg/l)在3个月时7例轻度升高、2年随访时2例轻度升高。
  • 术前铬水平除1例可检测到铬(1.2 µg/l)外均正常;铬在3个月时3例、1年时2例、2年随访时3例可检测到。
  • 流式细胞术显示循环白细胞谱保持稳定,但术后血清IL-4、IL-5和IFNγ较术前水平显著降低(p<0.05)。

关键数值与推荐

  • 血钴参考值1.0 µg/l。
  • 术前铬1.2 µg/l为可检测到。
  • 术后血清IL-4、IL-5和IFNγ较术前显著降低,p<0.05。

临床怎么用

  • 模块化双动全髋关节置换术允许使用大股骨头和厚聚乙烯承重面,在翻修或需要额外稳定性的高风险情况下尤其有用。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to evaluate blood metal ion levels, leucocyte profiles, and serum cytokines in patients with a total hip arthroplasty (THA) involving modular dual-mobility components. PATIENTS AND METHODS: A total of 39 patients were recruited, with clinical follow-up of up to two years. Outcome was assessed using the Harris Hip Score (HHS, the 12-Item Short-Form Health Survey (SF-12), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and a visual analogue scale (VAS) for pain. Blood concentrations of cobalt (Co), chromium (Cr), and serum cytokines were measured. Subpopulations of leucocytes were analyzed by flow cytometry. RESULTS: The clinical performance was good. Blood Co levels (ref 1.0 µg/l) were mildly elevated in seven patients at three months, and two patients at two years' follow-up. The preoperative Cr levels were normal except for one patient with a detectable Cr (1.2 µg/l). Cr levels were detectable in three patients at three months, two patients at one year, and three patients at two years' follow-up. No patients had symptoms suggestive of failure. Although flow cytometry showed constant circulating leucocyte profiles, there was a significant reduction of serum interleukin (IL)-4, IL-5, and interferon gamma (IFNγ) postoperatively compared with the preoperative levels (p < 0.05). CONCLUSION: These results suggest that THA using modular dual-mobility components is safe. This allows an opportunity to use a large femoral head and a thick polyethylene bearing surface, which is especially useful in revision procedures or high-risk situations when added stability is required. Cite this article: Bone Joint J 2019;101-B:1035-1041.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Markel DC, Bou-Akl T, Rossi MD, et al. Blood metal levels, leucocyte profiles, and cytokine profiles in patients with a modular dual-mobility hip prosthesis: early results from a prospective cohort study. Bone Joint J. 2019. PMID: 31474131. doi:10.1302/0301-620X.101B9.BJJ-2019-0377.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。